These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29028556)

  • 1. Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine.
    Reynolds AR; Strickland JC; Stoops WW; Lile JA; Rush CR
    Drug Alcohol Depend; 2017 Dec; 181():25-29. PubMed ID: 29028556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance.
    Rush CR; Stoops WW; Lile JA; Glaser PE; Hays LR
    Psychopharmacology (Berl); 2011 Apr; 214(3):665-74. PubMed ID: 21072503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute buspirone dosing enhances abuse-related subjective effects of oral methamphetamine.
    Pike E; Stoops WW; Rush CR
    Pharmacol Biochem Behav; 2016; 150-151():87-93. PubMed ID: 27697553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine.
    Marks KR; Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR
    J Clin Psychopharmacol; 2016 Jun; 36(3):213-21. PubMed ID: 27043121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans.
    Stoops WW; Bennett JA; Lile JA; Sevak RJ; Rush CR
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():111-7. PubMed ID: 23994622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance.
    Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR
    Drug Alcohol Depend; 2011 Dec; 119(3):187-93. PubMed ID: 21737214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers.
    De La Garza R; Zorick T; Heinzerling KG; Nusinowitz S; London ED; Shoptaw S; Moody DE; Newton TF
    Pharmacol Biochem Behav; 2009 Nov; 94(1):186-93. PubMed ID: 19698734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers.
    De La Garza R; Zorick T; London ED; Newton TF
    Drug Alcohol Depend; 2010 Jan; 106(2-3):173-80. PubMed ID: 19781865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans.
    Kirkpatrick MG; Gunderson EW; Johanson CE; Levin FR; Foltin RW; Hart CL
    Addiction; 2012 Apr; 107(4):783-91. PubMed ID: 22050030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine.
    Stoops WW; Pike E; Hays LR; Glaser PE; Rush CR
    Pharmacol Biochem Behav; 2015 Feb; 129():45-50. PubMed ID: 25459104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of phendimetrazine maintenance on the reinforcing, subjective, performance, and physiological effects of intranasal cocaine.
    Stoops WW; Strickland JC; Alcorn JL; Hays LR; Rayapati AO; Lile JA; Rush CR
    Psychopharmacology (Berl); 2019 Sep; 236(9):2569-2577. PubMed ID: 30900008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D3 receptors as a therapeutic target for methamphetamine dependence.
    Paterson NE; Vocci F; Sevak RJ; Wagreich E; London ED
    Am J Drug Alcohol Abuse; 2014 Jan; 40(1):1-9. PubMed ID: 24359505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine self-administration in humans during D-amphetamine maintenance.
    Pike E; Stoops WW; Hays LR; Glaser PE; Rush CR
    J Clin Psychopharmacol; 2014 Dec; 34(6):675-81. PubMed ID: 25154010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative reinforcer response cost impacts methamphetamine choice in humans.
    Bennett JA; Stoops WW; Rush CR
    Pharmacol Biochem Behav; 2013 Jan; 103(3):481-6. PubMed ID: 23046851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological and subjective effects of acute intranasal methamphetamine during atomoxetine maintenance.
    Rush CR; Stoops WW; Lile JA; Glaser PE; Hays LR
    Pharmacol Biochem Behav; 2011 Nov; 100(1):40-7. PubMed ID: 21802442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of buspirone for attenuating cocaine and methamphetamine reinstatement in rats.
    Shelton KL; Hendrick ES; Beardsley PM
    Drug Alcohol Depend; 2013 May; 129(3):210-6. PubMed ID: 23374566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of buspirone and the dopamine D3 receptor compound PG619 on cocaine and methamphetamine self-administration in rhesus monkeys using a food-drug choice paradigm.
    John WS; Banala AK; Newman AH; Nader MA
    Psychopharmacology (Berl); 2015 Apr; 232(7):1279-89. PubMed ID: 25327444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute physiological and behavioral effects of intranasal methamphetamine in humans.
    Hart CL; Gunderson EW; Perez A; Kirkpatrick MG; Thurmond A; Comer SD; Foltin RW
    Neuropsychopharmacology; 2008 Jul; 33(8):1847-55. PubMed ID: 17851535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acute topiramate dosing on methamphetamine-induced subjective mood.
    Johnson BA; Roache JD; Ait-Daoud N; Wells LT; Wallace CL; Dawes MA; Liu L; Wang XQ
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):85-98. PubMed ID: 16448579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study.
    Verrico CD; Haile CN; De La Garza R; Grasing K; Kosten TR; Newton TF
    Int J Neuropsychopharmacol; 2016 Jul; 19(7):. PubMed ID: 27207905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.